| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c163c101399a77181408b93dc02fe00d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-249 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24 |
| filingDate |
1987-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d29dfd2998de66616d735ee0a4807c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74c0303eb07ae9a26562eaeb5803a324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1edb9d6afd25a777f9abdd313dd9e008 |
| publicationDate |
1988-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
GB-2195342-A |
| titleOfInvention |
Antibodies to interferon |
| abstract |
A monoclonal antibody to IFN which inhibits the cell-binding capability of the IFN or which inhibits the cytotoxicity-boosting activity of the IFN mediated by NK cells can be obtained by raising anti-IFN monoclonal antibodies by techniques known per se and screening them for the desired inhibitory activity, then culturing the cell line which produces the selected monoclonal antibody. The IFN may be IFN alpha or especially, recombinant IFN alpha -2. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7087726-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7910707-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8557967-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7582445-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8349331-B2 |
| priorityDate |
1986-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |